MeCure Industries Plc has released its unaudited financial results for the second quarter ended June 30, 2025, reporting a pre-tax profit of N3.093 billion, representing an impressive 634% year-on-year (YoY) growth compared to Q2 2024.
On October 2, 2024, MeCure Industries Plc, one of Nigeria’s leading pharmaceutical companies, announced the sale of a 10% equity stake to Zrosk Investment Management Ltd.
MeCure Industries Plc has announced the successful acquisition of a 10% equity stake in the company by Zrosk Investment Management Ltd.
MeCure Industries PLC released its 2024 second quarter results, reporting a pre-tax profit of N1.33 billion.
The Board of Directors of MeCure Industries Plc has appointed Mr. Joseph Oyeyemi Babatunde and Mr. Tochukwu Chukwuneta Orajiaku as Independent Non-Executive Directors of the Company.
MeCure Industries Plc has launched a Track-and-trace solution to ensure product safety and elevate patient safety standards in Nigeria.
The three newly listed equities in the NGX have contributed about N179 billion to the exchange’s market cap in 2023.
